Secondary Logo

Journal Logo

Most Popular Articles

The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN)

El Khoudary, Samar R.; Greendale, Gail; Crawford, Sybil L.; More

Menopause. 26(10):1213-1227, October 2019.

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. 26(9):1071-1084, September 2019.

Dairy intake is not associated with improvements in bone mineral density or risk of fractures across the menopause transition: data from the Study of Women's Health Across the Nation

Wallace, Taylor C.; Jun, Shinyoung; Zou, Peishan; More

Menopause. 27(8):879-886, August 2020.

Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial

Hirschberg, Angelica Lindén; Sánchez-Rovira, Pedro; Presa-Lorite, Jesús; More

Menopause. 27(5):526-534, May 2020.

Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)

Lobo, Rogerio A.; Liu, James; Stanczyk, Frank Z.; More

Menopause. 26(7):720-727, July 2019.

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; More

Menopause. 27(12):1350-1356, December 2020.

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

Archer, David F.; Goldstein, Steven R.; Simon, James A.; More

Menopause. 26(6):611-621, June 2019.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Maki, Pauline M.; Kornstein, Susan G.; Joffe, Hadine; More

Menopause. 25(10):1069-1085, October 2018.

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; More

Menopause. 27(4):382-392, April 2020.

The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial

Nudy, Matthew; Jiang, Xuezhi; Aragaki, Aaron K.; More

Menopause. 27(11):1265-1273, November 2020.

Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis

Atsma, Femke; Bartelink, Marie-Louise E. L.; Grobbee, Diederick E.; More

Menopause. 13(2):265-279, March-April 2006.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Cycle and hormone changes during perimenopause: the key role of ovarian function

Burger, Henry G.; Hale, Georgina E.; Dennerstein, Lorraine; More

Menopause. 15(4):603-612, July-August 2008.

Dietary changes associated with improvement of metabolic syndrome components in postmenopausal women receiving two different nutrition interventions

Rodriguez-Cano, Ameyalli; Mier-Cabrera, Jennifer; Balas-Nakash, Margie; More

Menopause. 22(7):758-764, July 2015.

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Glazer, Clara; More

Menopause. 22(4):384-390, April 2015.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

  • Buy
Show: